Preparing independent, creative leaders in the pharmaceutical sciences and in the application of genetics and genomics to the development of safe, effective drugs for patients
The San Francisco Chronicle and the Bay Area News Group, which includes the San Jose Mercury News and Oakland Tribune, have published feature articles this week focused on The Kidney Project, an effort to develop the first implantable bioartificial kidney to treat end-stage renal disease.
Research at the UCSF School of Pharmacy to develop the first implantable bioartificial kidney recently received exceptional private support: $1 million from the family of the late philanthropists Harry and Diana Hind, and $50,000 from the Patterson Barclay Memorial Foundation.
Passengers who travel on American Airlines from September through October 2011 will learn about the surgically implantable bioartificial kidney being developed at UCSF as a permanent solution to end stage renal disease.
Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support
Research stalwarts draw funding for decades
New directions in translational research attract support
Expansion of the School’s...